These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3500393)

  • 1. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive for anti-HIV.
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Klin Wochenschr; 1987 Jul; 65(13):596-9. PubMed ID: 3498088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C; Meurer M; Fröschl M
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
    Papsidero LD; Poiesz BJ; Montagna RA
    Hybridoma; 1988 Apr; 7(2):117-28. PubMed ID: 2453451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted heterogeneity of antibody to gp120 and p24 in AIDS.
    Grimaldi LM; Roos RP; Devare SG; Robey WG; Casey JM; Gurney ME; Apatoff BR; Lazzarin D
    J Immunol; 1988 Jul; 141(1):114-7. PubMed ID: 2837506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.
    Norrby E; Biberfeld G; Chiodi F; von Gegerfeldt A; Nauclér A; Parks E; Lerner R
    Nature; 1987 Sep 17-23; 329(6136):248-50. PubMed ID: 3041232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
    Resnick L; Shapshak P
    Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide.
    Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC
    J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of HTLV III/LAV envelope protein.
    Bicker U
    Nature; 1986 Nov 27-Dec 3; 324(6095):307. PubMed ID: 3466037
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection and characterization of circulating immune complexes in HIV-related diseases.
    Carini C; D'Amelio R; Mezzaroma I; Aiuti F
    Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
    Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
    J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.
    Zweig M; Showalter SD; Bladen SV; Gilden RV; Arthur LO; Robey WG; Nara PL; Fischinger PJ
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):51-62. PubMed ID: 3259140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
    N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
    [No Abstract]   [Full Text] [Related]  

  • 16. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.
    Chiodi F; von Gegerfeldt A; Albert J; Fenyö EM; Gaines H; von Sydow M; Biberfeld G; Parks E; Norrby E
    J Med Virol; 1987 Sep; 23(1):1-9. PubMed ID: 3500271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of HIV vaccine.
    Robson B; Fishleigh RV; Morrison CA
    Nature; 1987 Jan 29-Feb 4; 325(6103):395. PubMed ID: 3468356
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans.
    Goudsmit J; Smit L; Krone WJ; Bakker M; van der Noordaa J; Gibbs CJ; Epstein LG; Gajdusek DC
    J Infect Dis; 1987 Feb; 155(2):327-31. PubMed ID: 3492573
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections.
    Hofbauer JM; Schulz TF; Hengster P; Larcher C; Zangerle R; Kofler H; Fritsch P; Wachter H; Dierich MP
    J Clin Microbiol; 1988 Jan; 26(1):116-20. PubMed ID: 3277988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
    Ranki A; Weiss SH; Valle SL; Antonen J; Krohn KJ
    Clin Exp Immunol; 1987 Aug; 69(2):231-9. PubMed ID: 3652531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.